ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/06/29 | 1,390 | 1,435 | 1,367 | 1,377 | +12 | +0.9% | 2,294,600 |
| 2023/06/28 | 1,465 | 1,474 | 1,328 | 1,365 | -92 | -6.3% | 3,593,200 |
| 2023/06/27 | 1,460 | 1,513 | 1,454 | 1,457 | -43 | -2.9% | 1,560,300 |
| 2023/06/26 | 1,475 | 1,528 | 1,469 | 1,500 | -8 | -0.5% | 1,453,900 |
| 2023/06/23 | 1,632 | 1,633 | 1,491 | 1,508 | -114 | -7% | 3,495,100 |
| 2023/06/22 | 1,586 | 1,694 | 1,581 | 1,622 | +20 | +1.2% | 3,739,600 |
| 2023/06/21 | 1,660 | 1,675 | 1,570 | 1,602 | -41 | -2.5% | 2,864,900 |
| 2023/06/20 | 1,520 | 1,685 | 1,456 | 1,643 | +83 | +5.3% | 6,597,000 |
| 2023/06/19 | 1,552 | 1,657 | 1,530 | 1,560 | +163 | +11.7% | 8,662,900 |
| 2023/06/16 | 1,397 | 1,397 | 1,397 | 1,397 | +300 | +27.3% | 193,800 |
| 2023/06/15 | 1,115 | 1,115 | 1,091 | 1,097 | -21 | -1.9% | 568,700 |
| 2023/06/14 | 1,131 | 1,135 | 1,116 | 1,118 | -10 | -0.9% | 314,700 |
| 2023/06/13 | 1,147 | 1,148 | 1,124 | 1,128 | -8 | -0.7% | 349,200 |
| 2023/06/12 | 1,098 | 1,140 | 1,095 | 1,136 | +37 | +3.4% | 550,900 |
| 2023/06/09 | 1,111 | 1,114 | 1,096 | 1,099 | -3 | -0.3% | 329,900 |
| 2023/06/08 | 1,104 | 1,112 | 1,096 | 1,102 | -1 | -0.1% | 252,200 |
| 2023/06/07 | 1,114 | 1,120 | 1,095 | 1,103 | -8 | -0.7% | 291,800 |
| 2023/06/06 | 1,103 | 1,119 | 1,096 | 1,111 | -3 | -0.3% | 279,300 |
| 2023/06/05 | 1,110 | 1,120 | 1,095 | 1,114 | +17 | +1.5% | 370,900 |
| 2023/06/02 | 1,125 | 1,130 | 1,095 | 1,097 | -26 | -2.3% | 433,700 |
| 2023/06/01 | 1,097 | 1,123 | 1,086 | 1,123 | +35 | +3.2% | 536,200 |
| 2023/05/31 | 1,095 | 1,096 | 1,081 | 1,088 | -10 | -0.9% | 330,500 |
| 2023/05/30 | 1,103 | 1,105 | 1,073 | 1,098 | -1 | -0.1% | 331,500 |
| 2023/05/29 | 1,091 | 1,114 | 1,076 | 1,099 | +20 | +1.9% | 388,200 |
| 2023/05/26 | 1,094 | 1,102 | 1,076 | 1,079 | -17 | -1.6% | 371,500 |
| 2023/05/25 | 1,140 | 1,147 | 1,088 | 1,096 | -34 | -3% | 614,200 |
| 2023/05/24 | 1,142 | 1,179 | 1,126 | 1,130 | -8 | -0.7% | 584,900 |
| 2023/05/23 | 1,116 | 1,155 | 1,105 | 1,138 | +35 | +3.2% | 934,600 |
| 2023/05/22 | 1,080 | 1,104 | 1,075 | 1,103 | +16 | +1.5% | 314,000 |
| 2023/05/19 | 1,085 | 1,103 | 1,075 | 1,087 | -5 | -0.5% | 401,900 |
| 2023/05/18 | 1,108 | 1,129 | 1,086 | 1,092 | -12 | -1.1% | 473,700 |
| 2023/05/17 | 1,113 | 1,123 | 1,082 | 1,104 | -19 | -1.7% | 626,400 |
| 2023/05/16 | 1,125 | 1,156 | 1,108 | 1,123 | +21 | +1.9% | 878,800 |
| 2023/05/15 | 1,080 | 1,103 | 1,072 | 1,102 | +22 | +2% | 457,100 |
| 2023/05/12 | 1,112 | 1,112 | 1,071 | 1,080 | -32 | -2.9% | 687,800 |
| 2023/05/11 | 1,121 | 1,146 | 1,108 | 1,112 | -16 | -1.4% | 677,000 |
| 2023/05/10 | 1,158 | 1,180 | 1,124 | 1,128 | -7 | -0.6% | 1,610,600 |
| 2023/05/09 | 1,091 | 1,207 | 1,091 | 1,135 | +104 | +10.1% | 4,954,900 |
| 2023/05/08 | 1,019 | 1,047 | 1,019 | 1,031 | +15 | +1.5% | 301,000 |
| 2023/05/02 | 1,010 | 1,022 | 1,005 | 1,016 | ±0 | ±0% | 324,700 |
| 2023/05/01 | 1,020 | 1,024 | 1,009 | 1,016 | -4 | -0.4% | 172,400 |
| 2023/04/28 | 1,018 | 1,025 | 998 | 1,020 | +16 | +1.6% | 333,500 |
| 2023/04/27 | 1,009 | 1,014 | 1,001 | 1,004 | -5 | -0.5% | 281,000 |
| 2023/04/26 | 1,019 | 1,027 | 1,007 | 1,009 | -20 | -1.9% | 475,800 |
| 2023/04/25 | 1,032 | 1,037 | 1,022 | 1,029 | -7 | -0.7% | 348,700 |
| 2023/04/24 | 1,041 | 1,052 | 1,035 | 1,036 | -9 | -0.9% | 180,100 |
| 2023/04/21 | 1,049 | 1,050 | 1,036 | 1,045 | -11 | -1% | 256,400 |
| 2023/04/20 | 1,063 | 1,073 | 1,049 | 1,056 | -13 | -1.2% | 266,000 |
| 2023/04/19 | 1,083 | 1,089 | 1,065 | 1,069 | -20 | -1.8% | 260,600 |
| 2023/04/18 | 1,076 | 1,100 | 1,073 | 1,089 | -2 | -0.2% | 400,700 |
451～
500
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.06倍 | 3.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 263,700円 | +15.0% | -7.3% | 2.65% | 8.65倍 | 0.82倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 234,300円 | +14.2% | +41.0% | 1.96% | 11.48倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 148,600円 | +8.8% | +99.9% | 3.50% | 9.49倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
